Yumiko Hayakawa Selected Research

Yumiko Hayakawa Research Topics

4	Glioma (Gliomas) 03/2019 - 03/2009
3	Glioblastoma (Glioblastoma Multiforme) 03/2019 - 01/2015
2	Neoplasms (Cancer) 01/2018 - 03/2009
2	Ischemic Stroke 01/2018 - 06/2016
2	Sickle Cell Anemia (Hemoglobin S Disease) 07/2013 - 03/2013
1	Lymphoma (Lymphomas) 06/2018
1	Hemorrhage 08/2014
1	Infections 01/2005

4	Protein Kinases (Protein Kinase)IBA 03/2019 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 03/2019 - 01/2015
2	OTS964IBA 03/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 06/2018 - 04/2018
2	Proteins (Proteins, Gene)FDA Link 04/2018 - 01/2005
2	Alprostadil (Muse)FDA LinkGeneric 01/2018 - 06/2016
2	Thrombin FDA Link 07/2013 - 01/2005
2	Heparin Cofactor IIIBA 03/2013 - 01/2005
1	protein kinase PIBA 06/2018
1	Messenger RNA (mRNA)IBA 04/2018
1	AntithrombinsIBA 03/2013
1	Plasminogen Activators (Plasminogen Activator)IBA 03/2013
1	Acridine OrangeIBA 03/2009
1	pitavastatin (itavastatin)FDA Link 03/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	Bisbenzimidazole (Hoechst 33258)IBA 03/2009
1	Interleukin-6 (Interleukin 6)IBA 01/2005
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2005

3	Therapeutics 03/2019 - 01/2015
1	Drug Therapy (Chemotherapy) 03/2019
1	Chemoradiotherapy 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Cell Transplantation 01/2018
1	Perioperative Period 08/2014